APA (7th ed.) Citation

F, P., & A, M. (2019). [LUTS in BPH patients: Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms]. Der Urologe. Ausg. A, 58(7), 795. https://doi.org/10.1007/s00120-019-0955-9

Chicago Style (17th ed.) Citation

F, Praus, and Miernik A. "[LUTS in BPH Patients: Comparison of Silodosin Versus Tamsulosin, Naftopidil, Alfuzosin and Placebo for the Treatment of Lower Urinary Tract Symptoms]." Der Urologe. Ausg. A 58, no. 7 (2019): 795. https://doi.org/10.1007/s00120-019-0955-9.

MLA (9th ed.) Citation

F, Praus, and Miernik A. "[LUTS in BPH Patients: Comparison of Silodosin Versus Tamsulosin, Naftopidil, Alfuzosin and Placebo for the Treatment of Lower Urinary Tract Symptoms]." Der Urologe. Ausg. A, vol. 58, no. 7, 2019, p. 795, https://doi.org/10.1007/s00120-019-0955-9.